Results 171 to 180 of about 84,117 (291)

Fruquintinib Plus TAS‐102 With or Without SBRT as Third‐ Or Later‐Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang, Jianfen Xu, Linchun Liang, Yunjie Chen, Leizheng Fei, Jing Hu, Jianjiong Li, Yi Lu, Feng Ren, Ke Chen, Yanping Shen, Qingsong Tao, Zhi Fang, Kaitai Liu, Hua Ye, Jing Zhang, Yunbao Xu, Haoxun Mao, Chen Zhang, Chuangzhou Rao   +19 more
wiley   +1 more source

Timeliness of postoperative serum carcinoembryonic antigen monitoring for predicting recurrence after gastric cancer surgery. [PDF]

World J Gastrointest Surg
Duan XX, Yu X, Zhou L.
europepmc   +1 more source

Efficacy of Hepatic Artery Infusion Chemotherapy Combined With Regorafenib and Sintilimab Versus Regorafenib Alone in MSS/pMMR Colorectal Cancer Liver Metastases After Second‐Line Treatment Failure

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Microsatellite stable/proficient mismatch repair (MSS/pMMR) colorectal cancer liver metastases (CRCLM) have limited treatment options after failure of second‐line systemic therapies. Hepatic artery infusion chemotherapy (HAIC) combined with targeted therapy and immunotherapy may offer improved outcomes.
Ran You, Qingyu Xu, Lixing Wang, Bin Leng, Chendong Wang, Zeyu Yu, Ya Lu, Lingfeng Diao, Yi Lu, Guowen Yin   +9 more
wiley   +1 more source

Predictive value of the combined application of oxidative stress indicators and carcinoembryonic antigen for patients with early lung adenocarcinoma. [PDF]

Am J Transl Res
Xu L, Lu C, Chen T, Zhang B.
europepmc   +1 more source

Mass Spectrometry‐Driven Proteomic Biomarkers for Serum‐Based Detection of Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm‐Associated Invasive Carcinoma

Cancer Medicine, Volume 15, Issue 5, May 2026.
LC‐MS/MS‐based serum profiling of 60 discovery samples has been achieved for pancreatic cancer biomarkers (IPMC and PDAC). ANOVA, ROC Analysis and Permutation Importance were applied for feature selection. 6‐Protein panel (CALR, FCN1, MBL2, SPP1, TAGLN2, and VWF) was validated using PRM analysis of 40 samples from independent cohort.
HyunGyo Jung, Namyoung Park, Jaihwan Kim, Min‐Jung Kang   +3 more
wiley   +1 more source

The preoperative albumin-to-carcinoembryonic antigen ratio (ACR) predicts prognosis and facilitates risk stratification in gastric cancer: a retrospective cohort study. [PDF]

Front Nutr
Yuan C, Wang W.
europepmc   +1 more source

Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19–9 as a Tool for Prognostic Evaluation in Neoadjuvant‐Treated Pancreatic Ductal Adenocarcinoma

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC) is highly thrombogenic and lethal, with rising incidence. Combining carbohydrate antigen (CA) 19–9, fibrinogen, coagulation factor VIII (FVIII), albumin, and alkaline phosphatase (ALP) as a diagnostic panel improves diagnostics.
Nora Mattila, Riitta Lassila, Harri Mustonen, Caj Haglund, Hanna Seppänen   +4 more
wiley   +1 more source

Carcinoembryonic Antigen [PDF]

, 2020
openaire   +1 more source

Primary Cardiac Lymphoma: A Diagnostically Challenging Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT This case highlights the diagnostic difficulties of PCL, including non‐specific symptoms, imaging mimics, and the critical role of histopathological confirmation despite technical and clinical challenges. Early multidisciplinary evaluation is essential to improve outcomes in this aggressive disease.
Yucheng Huang, Minxi Lao, Min Ye, Yang Yang, Meilin Ding, Jin Li, Lei Su   +6 more
wiley   +1 more source

Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer. [PDF]

Medicina (Kaunas)
Aytac A, Demir B, Gulmez MD, Arvas H, Tuzcu TU, Erul E, Tunbekici S, Yerlikaya T, Tunc S, Ellez HI, Camadan YA, Canaslan K, Colak R, Urakci Z, Koksoy EB, Yazici O, Alkan A, Tanriverdi O, Goker E, Demirkazik A.   +19 more
europepmc   +1 more source